JCCSX | SKSRX | JCCSX / SKSRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 20 years | - |
Gain YTD | 4.809 | 4.635 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | 1000 | - |
Net Assets | 916M | 928M | 99% |
Annual Yield % from dividends | 2.77 | 1.98 | 140% |
Returns for 1 year | 9.54 | 8.82 | 108% |
Returns for 3 years | 5.35 | 5.08 | 105% |
Returns for 5 years | 47.85 | 41.23 | 116% |
Returns for 10 years | N/A | 19.78 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFEPX | 20.43 | 0.19 | +0.94% |
NAA Large Core P | |||
PCBAX | 14.75 | 0.03 | +0.20% |
BlackRock Tactical Opportunities Inv A | |||
PQSCX | 24.99 | 0.02 | +0.08% |
Virtus KAR Small-Cap Value C | |||
ECASX | 28.97 | -0.02 | -0.07% |
Eaton Vance Atlanta Capital SMID-Cap C | |||
LYFCX | 12.39 | -0.10 | -0.80% |
AlphaCentric Life Sciences & Hlthcare C |